preloader

Email Us

info@prorelixresearch.com

Single Blog

Safety Monitoring Oversight Adds Value to Your Study

Researchers agree that the highest standards in clinical research need to be preserved to maintain the public’s confidence in their work, competence, and ethics. With patient safety as a primary consideration, the implementation of safety monitoring is paramount. One means of adding this value to a study is utilizing a Data Safety Monitoring Board (DSMB) and/or a Clinical Events Committee (CEC).

A Safety Monitoring Committee can have many different names, but they each have the same goals – patient safety and data integrity, will be sure to add value to your study.

  • Data monitoring committee
  • Data safety monitoring board
  • Clinical events committee
  • Medical monitoring group
  • A DSMB will review cumulative safety data, and possibly effectiveness data as well, and make recommendations to the sponsor regarding whether it feels the study should continue, continue with modifications, or be terminated. The overall goal of a safety monitoring group is always the same: additional, independent oversight of a study involving human subjects. A safety monitoring group such as a DSMB or CEC is an investment in safety and data integrity that goes beyond checking a box. Seek qualities in an independent, high-quality safety management team that will be sure to add value to the study.
  • The CEC instead reviews individual qualifying adverse events and provides adjudications to the sponsor, often to assess relatedness to the investigational product and/or study procedure.
  • The sponsor will determine if and what type of safety monitoring group will be needed based on study risks. The objectives and procedures may vary depending on the role of the safety monitoring group or depending on the risks involved in the study.

Niranjan Andhalkar

https://prorelixresearch.com/mr-niranjan-andhalkar/

( Director – Strategic Management & Planning ) - Mr. Niranjan Andhalkar is a visionary leader with more than 17 years of proven expertise in clinical research, strategic management, and business innovation. Recognized for his ability to blend entrepreneurial spirit with strategic foresight, he has successfully built, scaled, and transformed businesses across Contract Research Organizations (CROs), pharmaceuticals, healthcare IT. His dynamic leadership style and relentless pursuit of excellence have positioned him as a trusted figure in the international clinical research ecosystem. A seasoned strategist, Mr. Andhalkar is celebrated for his work to drive growth, enhance operational efficiency, and create sustainable value in highly competitive markets. He has an exceptional track record of fostering strategic alliances, steering multinational collaborations, and spearheading business innovations that have consistently set new benchmarks in the industry. His influence extends beyond corporate leadership, as he also contributes to the advancement of science and innovation through advisory and editorial roles in reputed international journals. Passionate about shaping the future of healthcare, Mr. Andhalkar is deeply committed to creating organizations that not only achieve financial success but also set new standards of quality, integrity, and impact in the industry. His leadership continues to inspire teams, empower clients, and redefine benchmarks across the global clinical research ecosystem. Mr. Andhalkar holds advanced academic credentials in both Life Sciences and Management. He earned his graduation in Biotechnology, followed by a postgraduate degree in Clinical Research, equipping him with deep scientific expertise. To complement his technical foundation, he pursued an MBA in Operations Management, which has enabled him to successfully integrate scientific rigor with business strategy—driving innovation, operational excellence, and long-term sustainability across his ventures.

Subscribe to our Newsletter

Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.

[fluentform id="3"]
prorelix research

ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.